作者：
Bookman,M.A. [1]
;
Gilks,C.B. [2]
;
Kohn,E.C. [3]
;
Kaplan,K.O. [4]
;
Huntsman,D. [5]
;
Aghajanian,C. [6]
;
Birrer,M.J. [7]
;
Ledermann,J.A. [8]
;
Oza,A.M. [9]
;
Swenerton,K.D. [10]
作者单位：
Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States
[1]
University of Arizona Cancer Center, 1515 N Campbell Ave, Tucson, AZ 85724-5024, United States
[2]
Department of Medical Oncology, Vancouver, BC, Canada
[3]
Pathology and Laboratory Medicine, Vancouver, BC, Canada, University of British Columbia, Vancouver
[4]
CR UK/UCL Cancer Trials Centre, University College London Cancer Institute, London, United Kingdom
[5]
Molecular Signalling Section, Medical Oncology Branch, National Cancer Institute, Bethesda, MD
[6]
Policy and Advocacy, Prevent Cancer Foundation, Alexandria, VA, United States
[7]
Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada
[8]
Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA, United
[9]
Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada
[10]
发布时间
2014-07-12
换一批
